JP6842970B2 - コエンザイムq10含有製剤 - Google Patents
コエンザイムq10含有製剤 Download PDFInfo
- Publication number
- JP6842970B2 JP6842970B2 JP2017068060A JP2017068060A JP6842970B2 JP 6842970 B2 JP6842970 B2 JP 6842970B2 JP 2017068060 A JP2017068060 A JP 2017068060A JP 2017068060 A JP2017068060 A JP 2017068060A JP 6842970 B2 JP6842970 B2 JP 6842970B2
- Authority
- JP
- Japan
- Prior art keywords
- coenzyme
- vitamin
- surfactant
- mass
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 title claims description 85
- 235000017471 coenzyme Q10 Nutrition 0.000 title claims description 85
- 229940110767 coenzyme Q10 Drugs 0.000 title claims description 85
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title claims description 85
- 238000002360 preparation method Methods 0.000 title description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 66
- 239000000203 mixture Substances 0.000 claims description 36
- 229930003427 Vitamin E Natural products 0.000 claims description 33
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 33
- 235000019165 vitamin E Nutrition 0.000 claims description 33
- 229940046009 vitamin E Drugs 0.000 claims description 33
- 239000011709 vitamin E Substances 0.000 claims description 33
- 239000004094 surface-active agent Substances 0.000 claims description 25
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 14
- 239000000194 fatty acid Substances 0.000 claims description 14
- 229930195729 fatty acid Natural products 0.000 claims description 14
- -1 glycerin fatty acid ester Chemical class 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 description 16
- 230000003078 antioxidant effect Effects 0.000 description 16
- 235000006708 antioxidants Nutrition 0.000 description 16
- 239000003826 tablet Substances 0.000 description 13
- 235000013305 food Nutrition 0.000 description 7
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- ARZCDYVIZADZJN-QXCSMICNSA-N (2r)-7,8-dimethoxy-2,5-dimethyl-2-[(3e,7e,11e,15e,19e,23e,27e,31e)-4,8,12,16,20,24,28,32,36-nonamethylheptatriaconta-3,7,11,15,19,23,27,31,35-nonaenyl]chromen-6-ol Chemical compound C1=C[C@@](C)(CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)OC2=C(OC)C(OC)=C(O)C(C)=C21 ARZCDYVIZADZJN-QXCSMICNSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- ARZCDYVIZADZJN-OBEXFZABSA-N Ubichromenol Natural products COc1c(O)c(C)c2C=C[C@@](C)(CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)Oc2c1OC ARZCDYVIZADZJN-OBEXFZABSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007561 laser diffraction method Methods 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Description
1.コエンザイムQ10、ビタミンE及びHLB4以下の界面活性剤を含有する、コエンザイムQ10含有組成物。
2.HLBが4以下の界面活性剤が、レシチン、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル又はショ糖脂肪酸エステルから選択される1種以上である、上記1のコエンザイムQ10含有組成物。
3.固形剤の形態である、上記1又は2のコエンザイムQ10含有組成物。
4.粉末の形態である、上記1〜3のコエンザイムQ10含有組成物。
5.界面活性剤の含有量が、組成物100質量%中5〜40質量%である、上記1〜4のコエンザイムQ10含有組成物。
有機酸の存在下、アラビアガム、寒天、水溶性コーンファイバー、デンプン、ゼラチン、キサンタンガム、カゼイン、デキストリン、カルメロースナトリウム、ポリビニルピロ
リドンからなる群から選択される1つ以上の水溶性物質にコエンザイムQ10を分散・乳化したもの。
コエンザイムQ10を、オクテニルコハク酸澱粉とデキストリンからなる水溶性物質およびグリセリンを含有する水性液体中で分散・乳化して、コエンザイムQ10 1〜50質量%、グリセリン0.01〜10質量%、水溶性物質4〜30質量%および水40〜94質量%を含有するコエンザイムQ10含有液体組成物とし、これを乾燥したもの。
コエンザイムQ10粉末、ビタミンE粉末(ビタミンE50%含有)、表2記載の添加物、結晶セルロース、還元麦芽糖及び滑沢剤(「ステアリン酸カルシウム」)を1粒当たりの量として表1記載の量でミキサーに投入して、5分間混合した。この混合物をロータリー式打錠機に投入し、打錠圧2000Nで打錠し、直径10mm、1粒当たり450mgの錠剤を製造した。別途、界面活性剤を加えずに還元麦芽糖で置き換えた参考例1の錠剤を製造した。
各実施例の錠剤を製造後にアルミパウチ袋に包装し、60℃で1週間保管した。その後錠剤を取出し、粉砕して含有するコエンザイムQ10量を高速液体クロマトグラフィーにより測定した。その結果のコエンザイムQ10残存量を表2に示す。また、参考例1に対する安定性の向上率を下記式で計算した。その結果を表2に示す。
安定性向上率=((実施例の残存率/参考例の残存率)−1)×100
水溶化コエンザイムQ10粉末(コエンザイムQ10を40%含有)、ビタミンE粉末(ビタミンE50%含有)、表4記載の添加物、結晶セルロース、還元麦芽糖及び滑沢剤(「ステアリン酸カルシウム」)を1粒当たりの量として表3記載の量でミキサーに投入して、5分間混合した。この混合物をロータリー式打錠機に投入し、打錠圧2000Nで打錠し、直径10mm、1粒当たり450mgの錠剤を製造した。別途、界面活性剤を加えずに還元麦芽糖で置き換えた参考例2の錠剤を製造した。これらの錠剤を、試験例1と同様にして評価した。その結果を表4に示す。
Claims (5)
- コエンザイムQ10、ビタミンE及びHLB2〜4の界面活性剤を含有する、コエンザイムQ10含有組成物。
- HLBが2〜4の界面活性剤が、HLB2〜4のグリセリン脂肪酸エステル、HLB2〜4のポリグリセリン脂肪酸エステル又はHLB2〜4のショ糖脂肪酸エステルから選択される1種以上である、請求項1記載のコエンザイムQ10含有組成物。
- 固形剤の形態である、請求項1又は2記載のコエンザイムQ10含有組成物。
- 粉末の形態である、請求項1〜3のいずれか1項に記載のコエンザイムQ10含有組成物。
- 界面活性剤の含有量が、組成物100質量%中5〜40質量%である、請求項1〜4のいずれか1項に記載のコエンザイムQ10含有組成物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017068060A JP6842970B2 (ja) | 2017-03-30 | 2017-03-30 | コエンザイムq10含有製剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017068060A JP6842970B2 (ja) | 2017-03-30 | 2017-03-30 | コエンザイムq10含有製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018168122A JP2018168122A (ja) | 2018-11-01 |
JP6842970B2 true JP6842970B2 (ja) | 2021-03-17 |
Family
ID=64018355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017068060A Active JP6842970B2 (ja) | 2017-03-30 | 2017-03-30 | コエンザイムq10含有製剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6842970B2 (ja) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4444586B2 (ja) * | 2003-06-10 | 2010-03-31 | 太陽化学株式会社 | コエンザイムq10含有組成物 |
JP2005002005A (ja) * | 2003-06-10 | 2005-01-06 | Nisshin Pharma Inc | コエンザイムq10含有組成物 |
JP4462401B2 (ja) * | 2003-07-18 | 2010-05-12 | 株式会社薬研 | いびき防止剤 |
JP2006151909A (ja) * | 2004-11-30 | 2006-06-15 | Rohto Pharmaceut Co Ltd | 内服用組成物 |
JP4997449B2 (ja) * | 2007-01-31 | 2012-08-08 | 株式会社ファンケル | 超臨界流体を用いた油脂コーティング複合化粒子の製法及び複合化粒子 |
JP3131917U (ja) * | 2007-03-08 | 2007-05-24 | 株式会社エルシーコーポレーション | ソフトカプセル |
WO2008156108A1 (ja) * | 2007-06-21 | 2008-12-24 | Kaneka Corporation | 機能性家畜生産品およびその製造方法 |
JP5483846B2 (ja) * | 2008-09-10 | 2014-05-07 | 丸大食品株式会社 | 鳥類ムネ肉から得られる機能性素材及びその製造方法 |
JP4899224B2 (ja) * | 2010-05-11 | 2012-03-21 | 春三 小林 | 動脈硬化改善剤 |
JP6016700B2 (ja) * | 2013-04-05 | 2016-10-26 | 富士フイルム株式会社 | 水中油型エマルション組成物 |
JP2015218140A (ja) * | 2014-05-19 | 2015-12-07 | 医療法人千清會 鈴木脳神経外科 | 抗酸化サプリメント |
-
2017
- 2017-03-30 JP JP2017068060A patent/JP6842970B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2018168122A (ja) | 2018-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI351925B (en) | Composition comprising coenzyme q10 | |
JPWO2006035900A1 (ja) | コエンザイムq10含有乳化組成物 | |
US8057819B2 (en) | Stability additives for dry DHA dosage forms | |
CN1741748A (zh) | 粉末状植物甾醇配方 | |
JP2004514419A (ja) | カロチノイドを含有する水分散性配合物の製造方法 | |
JP4859006B2 (ja) | 安定なアスタキサンチン−シクロデキストリン包接化合物及びその製造方法、並びに該包接化合物を含有する液剤、飲食物、飼料、医薬品及び化粧品 | |
KR20090008227A (ko) | 흡습성이 개선된 음식품용 조성물 | |
JP2019104712A (ja) | 阿膠含有粉末、これを含む錠剤及び食品、並びに阿膠含有粉末の製造方法 | |
JP4820288B2 (ja) | 食物繊維を含有する健康食品の製造方法 | |
JP2019510763A (ja) | ルテインおよび/またはゼアキサンチンの新規の錠剤化可能な製剤 | |
MX2015001930A (es) | Preparacion farmaceutica solida que contiene levotiroxina. | |
CA2951346C (en) | Composition in the form of compacted particles and use thereof | |
JP5432563B2 (ja) | ホスファチジルセリン含有カプセル及びカプセル充填用ホスファチジルセリン組成物 | |
JP6122538B2 (ja) | 内服組成物 | |
JP6842970B2 (ja) | コエンザイムq10含有製剤 | |
KR101420483B1 (ko) | 분말 유지 배합 저작용 소프트 캡슐 | |
JP5041565B2 (ja) | 安定なアスタキサンチンとγ−シクロデキストリンとの包接化合物及びその製造方法、並びに液剤、飲食物、飼料、医薬品及び化粧品用途 | |
JP2019135217A (ja) | 粉状組成物、粉状組成物の製造方法、ドライアイ改善剤、肌質改善剤、飲食物、化粧品、及びペットフード | |
JP2018002695A (ja) | 結晶セルロース混合粉末、組成物、及び成形体の製造方法 | |
JP6873014B2 (ja) | コエンザイムq10含有固形組成物 | |
JP4242475B2 (ja) | ビタミンk1組成物およびその製造法 | |
JP2018184387A (ja) | 固形組成物 | |
US11896716B2 (en) | Method for the formulation of oil-soluble substances, and powders obtainable thereof | |
JP2008061528A (ja) | 食品組成物 | |
JP2012077087A (ja) | 安定なアスタキサンチンとγ−シクロデキストリンとの包接化合物、並びにそれを含む飲食物、飼料及び医薬品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170407 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190823 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200623 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200819 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201020 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201120 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210126 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210222 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6842970 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |